Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+776.1%
5Y CAGR+292.5%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+776.1%/yr
Annual compound
5Y CAGR
+292.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
931.9x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.17 | +35.0% |
| 2023 | 3.09 | +8122.7% |
| 2022 | 0.04 | +505.7% |
| 2021 | 0.01 | -5.7% |
| 2020 | 0.01 | +47.0% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |